With both GBS and CIDP, the body’s immune system mistakenly attacks the peripheral nerves (the nerves that connect the brain and spinal cord to the body). Over time, nerves lose their ability to send signals to the rest of the body, leading to weakness, numbness, tingling, burning pain, and other nerve-related symptoms – sometimes referred to as demyelinating neuropathy. Conditions like Guillain-Barré Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) are both peripheral disorders, however, have different symptoms and progression timelines. Understanding these differences is the first step toward managing symptoms, regaining strength, and finding treatments that help you regain your everyday life.
How Does Autoimmune Peripheral Neuropathy Work?
Autoimmune diseases occur when the body’s immune system mistakenly attacks healthy tissues. With peripheral neuropathy, the immune system attacks the peripheral nerves outside the brain and spinal cord. This can lead to numbness, tingling, or pain in the hands and feet. Over time, the damage to these nerves can affect mobility, balance, and everyday function.
What is GBS?
Guillain-Barré Syndrome (GBS) is a rare, autoimmune condition that develops rapidly, often over a few hours, days, or weeks. It can cause sudden weakness, tingling, numbness, or even temporary paralysis, and in severe cases, difficulty breathing. The first signs of GBS can start with muscle weakness and/or tingling sensations. Symptoms usually affect both sides of your body and begin in your feet and legs and spread up to your arms and face. The severity of GBS can range from very mild to severe. Depending on the severity of the condition, other symptoms may include deep muscular pain in your back and/or legs, paralysis of your legs, arms and/or facial muscles and in severe cases, you may experience near-total paralysis. Chest muscle weakness can also occur, which can make it difficult to breathe. This affects about 1 in 3 people with GBS. Symptoms also include difficulty speaking and swallowing, and difficulty moving your eyes and vision issues. While the exact cause of GBS is unknown, in approximately two-thirds of cases, the condition is preceded by an infection within six weeks before symptoms begin. Infections can include respiratory, gastrointestinal, the Zika virus, or COVID-19. With treatment, most people fully recover from the condition.
What is CIDP?
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare, long-term autoimmune condition that slowly develops over at least 8 weeks with symptoms such as weakness, numbness, tingling, and fatigue. It typically affects the muscles on both sides of your body in the hips and thighs, shoulders and upper arms, hands, and feet. Other symptoms may include loss of muscle mass in affected muscles, tingling, prickliness, or numbness in your fingers and toes, difficulties with balance and coordination, loss of mobility, loss or weakening of deep tendon (muscle stretch) reflexes, and nerve pain. It can also improve and come back (relapse) over the course of months or years. Unlike GBS, CIDP is ongoing, meaning patients often need regular treatments to calm the immune system and prevent relapses.
GBS vs. CIDP
While both GBS and CIDP involve the immune system attacking the nerves, they differ in important ways.
| GBS | CIDP | |
| Onset | Progresses quickly over hours, several days or weeks, often after an infection | Develops slowly over ≥ 8 weeks. CIDP can come and go over time. |
| Duration | This condition is usually a one-time event. Symptoms peak quickly and get better over weeks to months. | This condition is long-term and often requires ongoing therapy. |
| Monitoring | Requires close monitoring during acute phases, typically in the hospital to watch for rapid weakness or breathing problems. | Requires continuous evaluations and possible treatment adjustments. |
| Treatment Goals | Stop the autoimmune attack on the nerves, manage acute symptoms, prevent complications, and support recovery. | Control the immune system, manage long-term symptoms, prevent relapse, and maintain quality of life. |
Treating GBS and CIDP with Immunoglobulin Therapy
IVIg and SCIg therapy are common treatments used for CIDP, while IVIg is used for GBS. IVIg and SCIg can lessen your immune system’s attack on your nerves and support recovery.
- For GBS patients, getting Immunoglobulin (Ig) treatment early can slow nerve damage progression and improve recovery.
- For CIDP patients, regular Immunoglobulin (Ig) therapy can help maintain function and prevent relapses.
Live Confidently with GBS or CIDP
Autoimmune neuropathies like GBS and CIDP may share some similarities; however, understanding how they differ is an important step to getting the right care and support. At CSI Pharmacy, we specialize in helping patients living with chronic and rare conditions access safe and effective Ig therapy at home. If you or someone you love is living with GBS or CIDP, contact us today to learn more about IVIg or SCIg for autoimmune neuropathy.